The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

被引:87
作者
Forrest, DM
Seminari, E
Hogg, RS
Yip, B
Raboud, J
Lawson, L
Phillips, P
Schechter, MT
O'Shaughnessy, MV
Montaner, JSG
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Fac Med, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada
[4] Univ British Columbia, Fac Med, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
[5] Canadian HIV Trials Network, Vancouver, BC, Canada
[6] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada
关键词
D O I
10.1086/515030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The incidence and spectrum of primary AIDS-defining illnesses in human immunodeficiency virus-positive patients receiving antiretroviral drugs may have changed since the introduction of newer antiretroviral agents. We performed a retrospective analysis of patients enrolled in the British Columbia Drug Treatment Program who were ever prescribed antiretroviral drugs between 1 January 1994 and 31 December 1996. Rates were calculated on a 6-month basis. There were 344 AIDS cases diagnosed among 2,533 participants between 1994 and 1996. The incidence of primary AIDS diseases decreased from 1994 to 1996, with a sharp decline in 1995 and 1996. There was no statistically significant change in the incidence of primary AIDS diagnoses relative to one another, and Pneumocystis carinii pneumonia and Kaposi's sarcoma remain the most common AIDS index diagnoses. In patients receiving antiretroviral therapy in the modern era, the incidence of AIDS-defining illnesses has decreased substantially, but the spectrum of AIDS-defining illnesses remains unchanged.
引用
收藏
页码:1379 / 1385
页数:7
相关论文
共 43 条
  • [11] DELMAS MC, 1995, J ACQ IMMUN DEF SYND, V9, P74
  • [12] Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: The Australian AIDS cohort
    Dore, GJ
    Li, YM
    Grulich, AE
    Hoy, JF
    Mallal, SA
    Mijch, AM
    French, MA
    Cooper, DA
    Kaldor, JM
    [J]. AIDS, 1996, 10 (12) : 1401 - 1406
  • [13] Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
    Foreman, KE
    Friborg, J
    Kong, WP
    Woffendin, C
    Polverini, PJ
    Nickoloff, BJ
    Nabel, GJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (03) : 163 - 171
  • [14] Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years
    Hermans, P
    Lundgren, J
    Sommereijns, B
    Pedersen, C
    Vella, S
    Katlama, C
    Luthy, R
    Pinching, AJ
    Gerstoft, J
    Pehrson, P
    Clumeck, N
    [J]. AIDS, 1996, 10 (08) : 911 - 917
  • [15] A CONTROLLED-STUDY OF INHALED PENTAMIDINE FOR PRIMARY PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    HIRSCHEL, B
    LAZZARIN, A
    CHOPARD, P
    OPRAVIL, M
    FURRER, HJ
    RUTTIMANN, S
    VERNAZZA, P
    CHAVE, JP
    ANCARANI, F
    GABRIEL, V
    HEALD, A
    KING, R
    MALINVERNI, R
    MARTIN, JL
    MERMILLOD, B
    NICOD, L
    SIMONI, L
    VIVIRITO, MC
    ZERBONI, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) : 1079 - 1083
  • [16] *HLTH CAN, 1997, AIDS CAN Q SURV UPD
  • [17] Decline in deaths from AIDS due to new antiretrovirals
    Hogg, RS
    OShaughnessy, MV
    Gataric, N
    Yip, B
    Craib, K
    Schechter, MT
    Montaner, JSG
    [J]. LANCET, 1997, 349 (9061) : 1294 - 1294
  • [18] Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
    Hogg, RS
    Heath, KV
    Yip, B
    Craib, KJP
    O'Shaughnessy, MV
    Schechter, MT
    Montaner, JSG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06): : 450 - 454
  • [19] CLINICAL MANIFESTATIONS OF AIDS IN THE ERA OF PNEUMOCYSTIS PROPHYLAXIS
    HOOVER, DR
    SAAH, AJ
    BACELLAR, H
    PHAIR, J
    DETELS, R
    ANDERSON, R
    KASLOW, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (26) : 1922 - 1926
  • [20] Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
    Jacobson, MA
    Zegans, M
    Pavan, PR
    ODonnell, JJ
    Sattler, F
    Rao, N
    Owens, S
    Pollard, R
    [J]. LANCET, 1997, 349 (9063) : 1443 - 1445